Identifying new drugs for patients with sickle cell disease is very important, said a senior scientist at the Indian Council ...

Doctors, nurses, caregivers, and loved ones are sharing their experiences being present for the final moments of someone's life...and hearing their last words.

Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Sickle cell disease is a genetic condition that affects the hemoglobin. With a holistic and lifestyle-first approach, this ...

To eliminate this disease by 2047, the country must deepen its focus on access, equity, and long-term continuity of care ...

Several people are unaware they are carriers of the sickle cell trait themselves, leading to further complications ...

Sickle Cell disease disproportionately affects India’s tribal populations, with complications impacting both children and ...

Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of ...

In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful improvements in hemoglobin (Hb) levels of ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...